These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20201018)

  • 1. The NLRP3 inflammasome, a target for therapy in diverse disease states.
    Cook GP; Savic S; Wittmann M; McDermott MF
    Eur J Immunol; 2010 Mar; 40(3):631-4. PubMed ID: 20201018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of adaptive immunity by the NLRP3 inflammasome.
    Chen M; Wang H; Chen W; Meng G
    Int Immunopharmacol; 2011 May; 11(5):549-54. PubMed ID: 21118671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterile inflammatory responses mediated by the NLRP3 inflammasome.
    Cassel SL; Sutterwala FS
    Eur J Immunol; 2010 Mar; 40(3):607-11. PubMed ID: 20201012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants.
    Harris J; Sharp FA; Lavelle EC
    Eur J Immunol; 2010 Mar; 40(3):634-8. PubMed ID: 20201019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling by ROS drives inflammasome activation.
    Martinon F
    Eur J Immunol; 2010 Mar; 40(3):616-9. PubMed ID: 20201014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inflammasome, an innate immunity guardian, participates in skin urticarial reactions and contact hypersensitivity.
    Kambe N; Nakamura Y; Saito M; Nishikomori R
    Allergol Int; 2010 Jun; 59(2):105-13. PubMed ID: 20179416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NLRP3 inflammasome: a sensor for metabolic danger?
    Schroder K; Zhou R; Tschopp J
    Science; 2010 Jan; 327(5963):296-300. PubMed ID: 20075245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasomes: guardians of cytosolic sanctity.
    Lamkanfi M; Dixit VM
    Immunol Rev; 2009 Jan; 227(1):95-105. PubMed ID: 19120479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the NLRP3 inflammasome: autoinflammatory diseases reach adolescence.
    Gattorno M; Martini A
    Arthritis Rheum; 2013 May; 65(5):1137-47. PubMed ID: 23400910
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome.
    Mitroulis I; Skendros P; Ritis K
    Eur J Intern Med; 2010 Jun; 21(3):157-63. PubMed ID: 20493414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical functions of priming and lysosomal damage for NLRP3 activation.
    Hornung V; Latz E
    Eur J Immunol; 2010 Mar; 40(3):620-3. PubMed ID: 20201015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nlrp3: an immune sensor of cellular stress and infection.
    Lamkanfi M; Kanneganti TD
    Int J Biochem Cell Biol; 2010 Jun; 42(6):792-5. PubMed ID: 20079456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the nature of autoinflammatory diseases from mice with Nlrp3 mutations.
    Meng G; Strober W
    Eur J Immunol; 2010 Mar; 40(3):649-53. PubMed ID: 20201022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inflammasome in pathogen recognition and inflammation.
    Sutterwala FS; Ogura Y; Flavell RA
    J Leukoc Biol; 2007 Aug; 82(2):259-64. PubMed ID: 17470531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inflammasome: a danger sensing complex triggering innate immunity.
    Pétrilli V; Dostert C; Muruve DA; Tschopp J
    Curr Opin Immunol; 2007 Dec; 19(6):615-22. PubMed ID: 17977705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives.
    Savic S; Dickie LJ; Wittmann M; McDermott MF
    Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):505-33. PubMed ID: 23040364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases.
    Zhong Z; Sanchez-Lopez E; Karin M
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):12-6. PubMed ID: 27586797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammasome and IL-1beta-mediated disorders.
    Hoffman HM; Wanderer AA
    Curr Allergy Asthma Rep; 2010 Jul; 10(4):229-35. PubMed ID: 20425006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The controversial relationship between NLRP3, alum, danger signals and the next-generation adjuvants.
    Spreafico R; Ricciardi-Castagnoli P; Mortellaro A
    Eur J Immunol; 2010 Mar; 40(3):638-42. PubMed ID: 20201020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity functional gene polymorphisms and gout susceptibility.
    Qing YF; Zhang QB; Zhou JG
    Gene; 2013 Jul; 524(2):412-4. PubMed ID: 23639963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.